MYRIAD GENETICS reports 2018 executive compensation

CEO Mark C. Capone receives $7.1M

MYRIAD GENETICS reported fiscal year 2018 executive compensation information on October 10, 2018.

In 2018, five executives at MYRIAD GENETICS received on average a compensation package of $3,441,391, a 33% increase compared to previous year.

Average pay of disclosed executives at MYRIAD GENETICS

Mark C. Capone, Chief Executive Officer, received $7,054,950 in total, which increased by 35% compared to 2017. 76.17% of Capone's compensation, or $5,374,050, was in stock awards. Capone also received $817,920 in non-equity incentive plan, $852,000 in salary, as well as $10,980 in other compensation.

Alexander Ford, President, Myriad Womens Health, Inc, received a compensation package of $2,760,945, which increased by 33% compared to previous year. 70.78% of the compensation package, or $1,954,200, was in stock awards.

R. Bryan Riggsbee, Chief Financial Officer, earned $2,645,582 in 2018, a 33% increase compared to previous year.

Jerry S. Lanchbury, Chief Scientific Officer, received $2,377,676 in 2018, which increases by 31% compared to 2017.

Richard M. Marsh, General Counsel, earned $2,367,801 in 2018, a 30% increase compared to previous year.

MYRIAD GENETICS' fiscal year ends on June 30.